NovoCure Limited (NASDAQ:NVCR) Q2 2024 Earnings Call Transcript

NovoCure Limited (NASDAQ:NVCR) Q2 2024 Earnings Call Transcript July 25, 2024

NovoCure Limited beats earnings expectations. Reported EPS is $-0.30989, expectations were $-0.4.

Operator: Good day and thank you for standing by. Welcome to the NovoCure Q2 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is...